Bio-Techne announces Q4 FY2022 earnings and quarterly cash dividend

BIO-TECHNE Corp

2022-FY EPS reported $6.63 revenue$1,105,599,000

Results for fiscal fourth quarter ended June 30, 2022; specific figures not available in provided text.
Cash dividend declared; amount, record date, and payable date not specified in filing text.
No other material events reported in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.